Imperial incubator opens doors to technology spin-outs:
This article was originally published in Clinica
UK technology transfer and commercialisation company Imperial Innovations has established a new facility, Imperial BioIncubator, to nurture young technology firms spun out from Imperial College. The incubator, based in the London campus of the university, offers office and laboratory space for up to 15 early-stage companies. The facility already houses seven occupants, including biomaterials developer Advanced Tissue Therapies and biotech company deltaDOT, and is expecting five more to move in shortly.
You may also be interested in...
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.